{'url': 'https://www.cancer.gov/news-events/cancer-currents-blog/2022/study-confirms-dinutiximab-high-risk-neuroblastoma', 'method': 'GET', 'status': 200, 'response_url': 'https://www.cancer.gov/news-events/cancer-currents-blog/2022/study-confirms-dinutiximab-high-risk-neuroblastoma', 'timestamp': 1711314630.7304869}